Preliminary Results from a FIH, Open-Label Phase 1 Study with BMC128, a Rationally Designed Live Bacterial Consortium, in Combination with Nivolumab.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2024)